Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal and fetal betamethasone pharmacokinetics in threatened preterm birth
NL-OMON56400Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of betamethasone in preterm birth, sponsored by Erasmus MC. Primary endpoint: Maternal and fetal betamethasone pharmacokinetics. Started Jan 2021; status: completed.
02
Drugs
betamethasone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NL-OMON56400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56400.